Catalent
CTLT
#1803
Rank
โ‚น1.051 T
Marketcap
โ‚น5,793
Share price
0.00%
Change (1 day)
19.96%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น577.64. In 2023 the company made an earnings per share (EPS) of -โ‚น620.53 a decrease over its 2022 EPS that were of โ‚น207.15.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-15.05%
2023-โ‚น620.53-399.56%
2022โ‚น207.15-30.58%
2021โ‚น298.4079.67%
2020โ‚น166.08114.12%
2019โ‚น77.57-15%
2018โ‚น91.2575.44%
2017โ‚น52.02-22.97%
2016โ‚น67.53-59.56%
2015โ‚น167.00282.05%
2014โ‚น43.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น30.11-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น543.88-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น68.44-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น135.06-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA